Addendum to 23rd AGM Notice: Re-appointment of Dr. Abhinay Bollineni
This is a routine update regarding AGM and director re-appointment. The impact on the company's operations or stock performance is minimal.
The announcement is a procedural update regarding the AGM and a director's re-appointment.
* Krishna Institute of Medical Sciences Limited issued an addendum to the notice for the 23rd Annual General Meeting (AGM) to be held on 29th August 2025, via video conferencing. * The addendum concerns Item No. 2 regarding the re-appointment of Dr. Abhinay Bollineni, who retires by rotation. * An annexure with additional information about Dr. Bollineni, required under Regulation 36(3) of the SEBI (LODR) Regulations, 2015, was initially not enclosed and is now included. * The AGM notice, along with the annexure, has been re-shared and uploaded to the company's website and the websites of BSE and NSE. * The original AGM notice was issued on 12th May 2025, and circulated on 7th August 2025.
What to do with a filing like this
Krishna Institute of Medical Sciences Limited filed this with the NSE as a statutory disclosure, categorised under agm-egm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krishna Institute of Medical Sciences Limited. Read the original for the full detail.